Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Mitra K Nadim, MD

    TitleProfessor of Clinical Medicine
    SchoolKeck School of Medicine of USC
    DepartmentMedicine
    AddressIRD 806
    Off Campus
    Los Angeles California 90089-9520
    Phone+1 323 226 7307
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      After graduating from UCLA Medical School, Dr. Nadim went to Boston for her internship and residency at the prestigious Beth Israel Hospital, which is affiliated with Harvard University’s School of Medicine. After completing a nephrology fellowship at Brigham and Women’s/Massachusetts General Hospital, Harvard University, Dr. Nadim returned to Southern California and currently serves as Professor of Clinical Medicine and Director of USC’s Hypertension Center. Dr. Nadim served as the Associate Program Director for the Nephrology Fellowship Program from 2003 – 2006.

      Dr. Nadim’s major clinical and research interests concerns the diagnosis and management of resistant hypertension. she is currently one of the National Principal Investigators in the Rheos Pivitol Trial, which is a multicenter clinical trial looking at efficacy and safety of the Rheos system, an implantable baroreflex device, in subjects with resistant hypertension.


      Collapse Biography 
      Collapse Awards and Honors
      Golden Key National Honor Society1988Member
      University of California, Irvine1989Phi Beta Kappa
      University of California, Irvine1990Cum Laude
      University of California, Irvine1990Excellence in Research Award
      National Kidney Foundation1999Volunteer/Donor Award
      Alpha Omega Alpha1992Research Fellowship Award
      National Institutes of Health1999National Research Service Award
      Keck School of Medicine of USC2004Outstanding Year II Teaching Award
      Keck School of Medicine of USC2007Medical Faculty Women's Award Research Grant
      Keck School of Medicine of USC2007Outstanding Year II Teaching Award
      Rheos Pivitol Trial 2008National Principal Investigator
      Keck School of Medicine of USC2008Outstanding Year II Course Award
      Keck School of Medicine of USC2011Outstanding Year II Teaching Award
      Keck School of Medicine of USC2011Master Teacher Award
      Keck School of Medicine2012Faculty Teaching Award
      Keck School of Medicine of USC2013Outstanding Year II Course Award
      Keck School of Medicine of USC2015Faculty Teaching Award

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. de Leeuw PW, Bisognano JD, Bakris GL, Nadim M, Haller H, Kroon AA. Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up. Hypertension. 2017 Mar 20. PMID: 28320856.
        View in: PubMed
      2. Kellum JA, Zarbock A, Nadim M. What endpoints should be used for clinical studies in acute kidney injury? Intensive Care Med. 2017 Mar 02. PMID: 28255614.
        View in: PubMed
      3. DiNorcia J, Meouchy J, Genyk YS, Nadim M. Perioperative Renal Replacement Therapy in Liver Transplantation. Int Anesthesiol Clin. 2017; 55(2):81-91. PMID: 28225534.
        View in: PubMed
      4. Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim M, Lovett EG, Schafer JE, de Leeuw PW. An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems. J Am Soc Hypertens. 2016 Dec 16. PMID: 28065708.
        View in: PubMed
      5. Nadim M, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS. Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective". J Hepatol. 2016 May 27. PMID: 27241199.
        View in: PubMed
      6. Francoz C, Nadim M, Durand F. Kidney biomarkers in cirrhosis. J Hepatol. 2016 Oct; 65(4):809-24. PMID: 27238754.
        View in: PubMed
      7. Durand F, Nadim M. Management of Acute-on-Chronic Liver Failure. Semin Liver Dis. 2016 May; 36(2):141-52. PMID: 27172356.
        View in: PubMed
      8. Nadim M, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. J Hepatol. 2016 Mar; 64(3):717-35. PMID: 26519602.
        View in: PubMed
      9. Durand F, Graupera I, Ginès P, Olson JC, Nadim M. Pathogenesis of Hepatorenal Syndrome: Implications for Therapy. Am J Kidney Dis. 2016 Feb; 67(2):318-28. PMID: 26500178.
        View in: PubMed
      10. Karvellas CJ, Durand F, Nadim M. Acute Kidney Injury in Cirrhosis. Crit Care Clin. 2015 Oct; 31(4):737-50. PMID: 26410141.
        View in: PubMed
      11. Al-Khafaji A, Nadim M, Kellum JA. Hepatorenal Disorders. Chest. 2015 Aug 1; 148(2):550-8. PMID: 25811649.
        View in: PubMed
      12. Fong MW, Shavelle D, Weaver FA, Nadim M. Renal denervation in heart failure. Curr Hypertens Rep. 2015 Apr; 17(4):528. PMID: 25754320.
        View in: PubMed
      13. Ghofrani H, Weaver FA, Nadim M. Resistant hypertension: medical management and alternative therapies. Cardiol Clin. 2015 Feb; 33(1):75-87. PMID: 25439332.
        View in: PubMed
      14. Nadim M, Annanthapanyasut W, Matsuoka L, Appachu K, Boyajian M, Ji L, Sedra A, Genyk YS. Intraoperative hemodialysis during liver transplantation: A decade of experience. Liver Transpl. 2014 Jul; 20(7):756-64. PMID: 24634344.
        View in: PubMed
      15. Francoz C, Nadim M, Baron A, Prié D, Antoine C, Belghiti J, Valla D, Moreau R, Durand F. Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: Validation of current recommendations. Hepatology. 2014 Apr; 59(4):1514-21. PMID: 24037821.
        View in: PubMed
      16. Nadim M, Sung RS. Living donor liver transplantation for hepatorenal syndrome: To do or not to do? That is the question. Liver Transpl. 2012 Oct; 18(10):1138-9. PMID: 22740330.
        View in: PubMed
      17. Nadim M, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012 Nov; 12(11):2901-8. PMID: 22822723.
        View in: PubMed
      18. Nadim M, Davis CL, Sung R, Kellum JA, Genyk YS. Simultaneous liver-kidney transplantation: a survey of US transplant centers. Am J Transplant. 2012 Nov; 12(11):3119-27. PMID: 22759208.
        View in: PubMed
      19. Nadim M, Genyk YS, Tokin C, Fieber J, Ananthapanyasut W, Ye W, Selby R. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome. Liver Transpl. 2012 May; 18(5):539-48. PMID: 22250075.
        View in: PubMed
      20. Bakris GL, Nadim M, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens. 2012 Mar-Apr; 6(2):152-8. PMID: 22341199.
        View in: PubMed
      21. Nadim M, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS. Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2012; 16(1):R23. PMID: 22322077.
        View in: PubMed
      22. Davenport A, Ahmad J, Al-Khafaji A, Kellum JA, Genyk YS, Nadim M. Medical management of hepatorenal syndrome. Nephrol Dial Transplant. 2012 Jan; 27(1):34-41. PMID: 22287700.
        View in: PubMed
      23. Bisognano JD, Bakris G, Nadim M, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011 Aug 9; 58(7):765-73. PMID: 21816315.
        View in: PubMed
      24. Wong F, Nadim M, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011 May; 60(5):702-9. PMID: 21325171.
        View in: PubMed
      25. Tokin C, Almeda J, Jain S, Kim J, Henderson R, Nadim M, Sher L, Selby RR. Blood-management programs: a clinical and administrative model with program implementation strategies. Perm J. 2009; 13(1):18-28. PMID: 21373242.
        View in: PubMed
      26. Pannu N, Nadim M. An overview of drug-induced acute kidney injury. Crit Care Med. 2008 Apr; 36(4 Suppl):S216-23. PMID: 18382197.
        View in: PubMed
      27. Campese VM, Nadim M, Epstein M. Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? J Am Soc Nephrol. 2005 Mar; 16 Suppl 1:S11-7. PMID: 15938026.
        View in: PubMed
      28. Nadim M, Dua R, Campese VM. Antihypertensive drugs and the kidney. Curr Cardiol Rep. 2004 Nov; 6(6):403-8. PMID: 15485598.
        View in: PubMed